Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 2

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 2
---

Ordinary Shares

American Depositary Shares representing Ordinary Shares

Debt Securities

Warrants

Rights

Units</div>

This prospectus will allow
us to issue, from time to time at prices and on terms to be determined at or prior to the time of the offering, up to $100,000,000 of
any combination of the securities described in this prospectus, either individually or in units. We may also offer American Depositary
Shares, or Depositary Shares, representing ordinary shares, nominal value £0.000001 per share, or Ordinary Shares, upon the exercise
of warrants or conversion of or exchange for debt securities.

This prospectus describes
the general terms of these securities and the general manner in which these securities will be offered. We will provide you with the specific
terms of any offering in one or more supplements to this prospectus. The prospectus supplements will also describe the specific manner
in which these securities will be offered and may also supplement, update or amend information contained in this document. You should
read this prospectus and any prospectus supplement, as well as any documents incorporated by reference into this prospectus or any prospectus
supplement, carefully before you invest.

Our securities may be sold
directly by us to you, through agents designated from time to time or to or through underwriters or dealers. For additional information
on the methods of sale, you should refer to the section titled “Plan of Distribution” in this prospectus and in the applicable
prospectus supplement. If any underwriters or agents are involved in the sale of our securities with respect to which this prospectus
is being delivered, the names of such underwriters or agents and any applicable fees, commissions or discounts and over-allotment options
will be set forth in a prospectus supplement. The price to the public of such securities and the net proceeds that we expect to receive
from such sale will also be set forth in a prospectus supplement.

Our Depositary Shares, each
representing 100,000 Ordinary Shares, are listed on The NASDAQ Capital Market under the symbol “BDRX.” The last reported closing
price of our Depositary Shares on The NASDAQ Capital Market on September 25, 2025 was $6.61.

The applicable prospectus
supplement will contain information, where applicable, as to any other listing, if any, on The NASDAQ Capital Market or any securities
market or other securities exchange of the securities covered by the prospect